Billionaire Profile
Albert Boehringer
Global Rank
#669

Image: Public domain | via Wikimedia Commons

Albert Boehringer

CEO, Boehringer Ingelheim
DE
Real-Time Net Worth
$5.7B
As of December 2025
Age
84
Source
Pharmaceuticals
Industry
healthcare
Citizenship
DE

Biography

Albert Boehringer (born August 11, 1861) is a German chemist and industrialist, best known as the founder of Boehringer Ingelheim, one of the world's largest privately-held pharmaceutical companies. His journey began in 1885 with a small chemical factory producing ingredients for pharmacies. Over a century later, the company, still headquartered in Ingelheim, Germany, employs over 54,500 people worldwide. Boehringer’s vision and early adoption of biotechnology helped pioneer large-scale lactic acid production. Today, Boehringer Ingelheim is a global leader in healthcare, focused on innovation in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Albert Boehringer's legacy continues through his family's ongoing involvement in the company.

Wealth Over Time

In-Depth Profile

Early Life

Albert Boehringer was born on August 11, 1861, in Stuttgart, Germany. He received training in chemistry, including studies in Munich. Boehringer's entrepreneurial spirit was evident early on, as he later acquired a small tartar factory in Nieder-Ingelheim in 1885.

Rise to Success

In 1885, Albert Boehringer founded C. H. Boehringer Sohn, a chemical and pharmaceutical company, with a focus on producing tartaric acid salts. The company’s success was fueled by his groundbreaking discovery in 1893: the mass production of lactic acid using bacteria. This breakthrough positioned Boehringer as a pioneer in large-scale biotechnological production. Over time, the company expanded, moving into the pharmaceutical sector and launching its first drug, Laudanon, in 1912. By the time of his death in 1939, the company employed approximately 1,500 people.

Key Business Strategies

Boehringer's focus on research and development was a cornerstone of the company's strategy, with a formal research department established in 1917. His early commitment to employee welfare, including health insurance and pension schemes, fostered a strong corporate culture. The decision to remain a family-owned company allowed for a long-term approach to innovation. The company's emphasis on sustainability, research and development, and employee welfare has contributed to its ongoing success.

Philanthropy

Information on Albert Boehringer's personal philanthropy could not be located, but his company, Boehringer Ingelheim, is involved in many publically funded research projects.

Career Milestones

1885

Founded C. H. Boehringer Sohn

Founded a chemical and pharmaceutical company that would later become Boehringer Ingelheim.

1893

Pioneered Lactic Acid Production

Discovered a method to produce lactic acid using bacteria on an industrial scale, revolutionizing the industry.

1912

Launched Laudanon

Launched the company's first pharmaceutical specialty, an analgesic based on opium alkaloids.

1917

Established Research Department

Established a formal research department to foster innovation in pharmaceuticals.